Roles of RORalpha in breast cancer development and progression
RORalpha 在乳腺癌发生和进展中的作用
基本信息
- 批准号:10199950
- 负责人:
- 金额:$ 11.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAgonistBiological AssayBiologyBreastBreast Cancer CellBreast Cancer ModelBreast Epithelial CellsCell PolarityCellular Metabolic ProcessChronicCoculture TechniquesComplexDevelopmentDown-RegulationEpithelial CellsGene ExpressionGene Expression ProfilingGenerationsGlutathione DisulfideGoalsHumanHydrogen PeroxideImmunocompetentInfiltrationInflammationKnockout MiceKnowledgeLeadLinkMalignant NeoplasmsMeasurementMediatingMetabolicMetforminMitochondriaModelingMolecularMusNADPNatureNeoplasm MetastasisNuclear Orphan ReceptorOxidation-ReductionPathway interactionsPositioning AttributeProductionReactive Oxygen SpeciesResearchRoleSchemeSourceStructureSuperoxidesSystemTP53 geneTestingTissue MicroarrayTissuesTumor Suppressor Proteinsbasebreast cancer progressioncancer cellcancer preventioncancer therapycytokinedruggable targethealingimprovedinhibitor/antagonistinsightknock-downloss of functionmacrophagemalignant breast neoplasmmammarymetabolomicsmonocytemultidisciplinarynovelnovel strategiesstable isotopetranscriptometumortumor microenvironmenttumor progressionwound
项目摘要
ABSTRACT
Tumor has been described as the wounds that do not heal. The two share some common features, such as
loss of polarized tissue structure and chronic inflammation. We showed that disruption of tissue polarity
induced macrophage infiltration. However, little is known of how disruption of epithelial cell polarity at early
stage of breast cancer development induces macrophage infiltration. We have identified the RAR-related
orphan nuclear receptor α (RORα) as a potent tumor suppressor by analyzing global gene expression profiles
in polarized and non-polarized mammary epithelial cells. Our recent findings show that RORα inhibits ROS
generation and macrophage infiltration in the syngeneic mouse mammary tumor model. These results suggest
that RORα is a potent suppressor of macrophage infiltration in mammary epithelial cells. We found that
knockdown of RORα significantly induced ROS production in mammary epithelial cells. Reactive oxygen
species (ROS) are the driver of cancer progression and critical regulator of the NF-κB pathway. Based on
these novel findings, the central hypothesis of our proposal is that downregulation of RORα in non-polarized
breast cancer cells increased ROS generation in mitochondria, thereby inducing NF-κB and macrophage
infiltration. We integrate high-throughput metabolic analysis, a novel 3D co-culture system, and global gene
expression profiling to delineate mechanisms by which RORα inhibits ROS production and macrophage
infiltration. The long-term goal of this proposal is to define the impact of the RORα/ROS axis in mediating
mammary epithelial cell-macrophage crosstalk and in regulating breast cancer progression. We have proposed
following specific aims to test the hypothesis: Aim 1. To elucidate the molecular mechanisms by which RORα
reduces ROS levels and NF-κB activity in polarized mammary epithelial cells; Aim 2. To determine how
reduced RORα expression in non-polarized breast cancer cells induces macrophage infiltration and M2
polarization; Aim 3. Define the impact of RORα in suppressing breast cancer formation and metastasis. The
proposed study is high impact for its inherent scientific importance and its translational potential. This study will
elucidate the molecular mechanism by which disruption of tissue polarity induces macrophage
infiltration/differentiation. Determining roles of RORα in reducing ROS generation and inhibiting NF-κB
activation may identify a novel strategy to inhibit breast cancer development and progression.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ren Xu其他文献
Ren Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ren Xu', 18)}}的其他基金
Roles of mRNA Transfer in Cancer Cell-Platelet Communication
mRNA 转移在癌细胞-血小板通讯中的作用
- 批准号:
10748535 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
The PLOD2/succinate axis in cancer cell plasticity and stemness
PLOD2/琥珀酸轴在癌细胞可塑性和干细胞性中的作用
- 批准号:
10680932 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
Roles of Hsp47 in Breast Cancer Progression
Hsp47 在乳腺癌进展中的作用
- 批准号:
10529483 - 财政年份:2017
- 资助金额:
$ 11.29万 - 项目类别:
Roles of RORalpha in breast cancer development and progression
RORalpha 在乳腺癌发生和进展中的作用
- 批准号:
10440464 - 财政年份:2017
- 资助金额:
$ 11.29万 - 项目类别:
Roles of Hsp47 in Breast Cancer Progression
Hsp47 在乳腺癌进展中的作用
- 批准号:
10701814 - 财政年份:2017
- 资助金额:
$ 11.29万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 11.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 11.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 11.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)